Baby botulism surge reveals FDA's regulatory gaps and corporate accountability failures
Original framing: “Baby botulism outbreak: FDA still doesn't know cause—or how to prevent it” — Ars Technica
The FDA's inability to trace the botulism source echoes past public health failures, such as the 1930s milk contamination crisis, where corporate influence delayed regulatory action. Historical parallels show how delayed accountability and fragmented oversight lead to preventable health crises.
The baby botulism outbreak is not an isolated incident but a symptom of deeper systemic failures in food safety regulation and corporate accountability.
By integrating Indigenous knowledge, strengthening regulatory independence, and leveraging technology for transparency, we can build a more resilient food system. Historical parallels and cross-cultural practices offer valuable insights into alternative models of food safety that prioritize community health over profit. A holistic approach that includes marginalized voices and scientific rigor is essential to prevent future crises.